Evaluation of analogues of furan-amidines as inhibitors of NQO2

Research output: Contribution to journalArticle

View graph of relations Save citation

Open

Authors

  • S. Alnabulsi
  • B. Hussein
  • E. Santina
  • I. Alsalahat
  • M. Kadirvel
  • R.N. Magwaza
  • R.A. Bryce
  • Carl H Schwalbe
  • A.G. Baldwin
  • I. Russo
  • I.J. Stratford
  • S. Freeman

Abstract

Inhibitors of the enzyme NQO2 (NRH: quinone oxidoreductase 2) are of potential use in cancer chemotherapy and malaria. We have previously reported that non-symmetrical furan amidines are potent inhibitors of NQO2 and here novel analogues are evaluated. The furan ring has been changed to other heterocycles (imidazole, N-methylimidazole, oxazole, thiophene) and the amidine group has been replaced with imidate, reversed amidine, N-arylamide and amidoxime to probe NQO2 activity, improve solubility and decrease basicity of the lead furan amidine. All compounds were fully characterised spectroscopically and the structure of the unexpected product N-hydroxy-4-(5-methyl-4-phenylfuran-2-yl)benzamidine was established by X-ray crystallography. The analogues were evaluated for inhibition of NQO2, which showed lower activity than the lead furan amidine. The observed structure-activity relationship for the furan-amidine series with NQO2 was rationalized by preliminary molecular docking and binding mode analysis. In addition, the oxazole-amidine analogue inhibited the growth of Plasmodium falciparum with an IC50 value of 0.3 μM.

Documents

Details

Original languageEnglish
JournalBioorganic and Medicinal Chemistry Letters
Early online date12 Mar 2018
DOIs
Publication statusE-pub ahead of print - 12 Mar 2018

Bibliographic note

© 2018, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/. Funding: Jordan University of Science and Technology, Irbid, and Al-Zaytoonah University, Jordan.

    Keywords

  • NQO2 inhibitors; Furan-amidines; Isosteres; Anti-cancer; Malaria; SAR

Employable Graduates; Exploitable Research

Copy the text from this field...